159 related articles for article (PubMed ID: 2193530)
1. Hepatic apo B-100 lipoproteins and plasma LDL heterogeneity in African green monkeys.
Murthy VN; Marzetta CA; Rudel LL; Zech LA; Foster DM
Am J Physiol; 1990 Jun; 258(6 Pt 1):E1041-57. PubMed ID: 2193530
[TBL] [Abstract][Full Text] [Related]
2. Metabolic behavior of hepatic VLDL and plasma LDL apoB-100 in African green monkeys.
Marzetta CA; Johnson FL; Zech LA; Foster DM; Rudel LL
J Lipid Res; 1989 Mar; 30(3):357-70. PubMed ID: 2723543
[TBL] [Abstract][Full Text] [Related]
3. Hepatic and intestinal contribution of two forms of apolipoprotein B to plasma lipoprotein fractions in the rat.
Sparks CE; Hnatiuk O; Marsh JB
Can J Biochem; 1981 Aug; 59(8):693-9. PubMed ID: 7296351
[TBL] [Abstract][Full Text] [Related]
4. Metabolism of apoB-100 in lipoproteins separated by density gradient ultracentrifugation in normal and Watanabe heritable hyperlipidemic rabbits.
Shames DM; Yamada N; Havel RJ
J Lipid Res; 1990 May; 31(5):753-62. PubMed ID: 2380627
[TBL] [Abstract][Full Text] [Related]
5. Psyllium husk. II: Effect on the metabolism of apolipoprotein B in African green monkeys.
McCall MR; Mehta T; Leathers CW; Foster DM
Am J Clin Nutr; 1992 Aug; 56(2):385-93. PubMed ID: 1322033
[TBL] [Abstract][Full Text] [Related]
6. Conversion of plasma VLDL and IDL precursors into various LDL subpopulations using density gradient ultracentrifugation.
Marzetta CA; Foster DM; Brunzell JD
J Lipid Res; 1990 Jun; 31(6):975-84. PubMed ID: 2373965
[TBL] [Abstract][Full Text] [Related]
7. Metabolic basis of hyperapobetalipoproteinemia. Turnover of apolipoprotein B in low density lipoprotein and its precursors and subfractions compared with normal and familial hypercholesterolemia.
Teng B; Sniderman AD; Soutar AK; Thompson GR
J Clin Invest; 1986 Mar; 77(3):663-72. PubMed ID: 3949973
[TBL] [Abstract][Full Text] [Related]
8. The magnitude of decrease in hepatic very low density lipoprotein apolipoprotein B secretion is determined by the extent of 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition in miniature pigs.
Burnett JR; Wilcox LJ; Telford DE; Kleinstiver SJ; Barrett PH; Newton RS; Huff MW
Endocrinology; 1999 Nov; 140(11):5293-302. PubMed ID: 10537160
[TBL] [Abstract][Full Text] [Related]
9. Development of an integrated model for analysis of the kinetics of apolipoprotein B in plasma very low density lipoproteins, intermediate density lipoproteins, and low density lipoproteins.
Beltz WF; Kesäniemi YA; Howard BV; Grundy SM
J Clin Invest; 1985 Aug; 76(2):575-85. PubMed ID: 4031063
[TBL] [Abstract][Full Text] [Related]
10. Regulation of the production and catabolism of plasma low density lipoproteins in hypertriglyceridemic subjects. Effect of weight loss.
Ginsberg HN; Le NA; Gibson JC
J Clin Invest; 1985 Feb; 75(2):614-23. PubMed ID: 3973021
[TBL] [Abstract][Full Text] [Related]
11. Characterization of nascent lipoproteins produced by perfused rat liver: evidence of hepatic secretion and post-secretory modification of nascent lipoproteins.
Teramoto T; Watanabe T; Matsushima T; Horie Y; Oka H
J Biochem; 1990 Apr; 107(4):519-25. PubMed ID: 2358425
[TBL] [Abstract][Full Text] [Related]
12. Apolipoprotein B metabolism in subjects with deficiency of apolipoproteins CIII and AI. Evidence that apolipoprotein CIII inhibits catabolism of triglyceride-rich lipoproteins by lipoprotein lipase in vivo.
Ginsberg HN; Le NA; Goldberg IJ; Gibson JC; Rubinstein A; Wang-Iverson P; Norum R; Brown WV
J Clin Invest; 1986 Nov; 78(5):1287-95. PubMed ID: 3095375
[TBL] [Abstract][Full Text] [Related]
13. Increased binding of LDL and VLDL to apo B,E receptors of hepatic plasma membrane of rats treated with Fibernat.
Venkatesan N; Devaraj SN; Devaraj H
Eur J Nutr; 2003 Oct; 42(5):262-71. PubMed ID: 14569407
[TBL] [Abstract][Full Text] [Related]
14. Evidence for kinetic heterogeneity among human low density lipoproteins.
Foster DM; Chait A; Albers JJ; Failor RA; Harris C; Brunzell JD
Metabolism; 1986 Aug; 35(8):685-96. PubMed ID: 3736409
[TBL] [Abstract][Full Text] [Related]
15. Regulation of low density lipoprotein apoprotein B metabolism by lovastatin and cholestyramine in miniature pigs: effects on LDL composition and synthesis of LDL subfractions.
Huff MW; Telford DE
Metabolism; 1989 Mar; 38(3):256-64. PubMed ID: 2918845
[TBL] [Abstract][Full Text] [Related]
16. Heterogeneity in the low density lipoproteins of cholesterol fed African green monkeys (Cercopithecus aethiops).
Melchior GW; Rudel LL
Biochim Biophys Acta; 1978 Dec; 531(3):331-43. PubMed ID: 216395
[TBL] [Abstract][Full Text] [Related]
17. Influence of obesity on the metabolism of apolipoprotein B in humans.
Egusa G; Beltz WF; Grundy SM; Howard BV
J Clin Invest; 1985 Aug; 76(2):596-603. PubMed ID: 4031064
[TBL] [Abstract][Full Text] [Related]
18. Splanchnic metabolism of plasma apolipoprotein B: studies of artery-hepatic vein differences of mass and radiolabel in fasted human subjects.
Turner PR; Miller NE; Cortese C; Hazzard W; Coltart J; Lewis B
J Clin Invest; 1981 Jun; 67(6):1678-86. PubMed ID: 7240415
[TBL] [Abstract][Full Text] [Related]
19. Role of apolipoprotein E on cholesteryl ester-enriched low density lipoprotein particles in coronary artery atherosclerosis of hypercholesterolemic nonhuman primates.
Stevenson SC; Sawyer JK; Rudel LL
Arterioscler Thromb; 1992 Jan; 12(1):28-40. PubMed ID: 1731856
[TBL] [Abstract][Full Text] [Related]
20. Roles of apolipoproteins B and E in the cellular binding of very low density lipoproteins.
Krul ES; Tikkanen MJ; Cole TG; Davie JM; Schonfeld G
J Clin Invest; 1985 Feb; 75(2):361-9. PubMed ID: 3973009
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
